Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Pala

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2019
Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative TumorsFabio Conforti, Laura Pala
Expert Opinion on Drug Safety|September 1, 2021
The effect of patient sex on the efficacy and safety of anticancer immunotherapyLaura Pala, Fabio Conforti
Acta Diabetologica|April 15, 2008
Time to insulin in type-2 diabetes: high hurdles or Santiago way?Carlo Maria Rotella, Laura Pala
Oncotarget|August 23, 2018
Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune systemFabio Conforti, Laura Pala, Aron Goldhirsch
Molecules (Basel, Switzerland)|August 23, 2020
Modified Enzyme Substrates for the Detection of Bacteria: A ReviewLaura Pala, Teja Sirec, Urs Spitz
The Lancet. Oncology|March 6, 2020
Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapyLaura Pala, Fabio Conforti, Aron Goldhirsch
Acta Diabetologica|April 5, 2019
Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trialsLaura Pala, Ilaria Dicembrini, Edoardo Mannucci
The New England Journal of Medicine|February 19, 2025
Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast CancerFabio Conforti, Chiara Oriecuia, Laura Pala
International Journal of Endocrinology and Metabolism|December 19, 2013
Role of insulin in the type 2 diabetes therapy: past, present and futureCarlo Maria Rotella, Laura Pala, Edoardo Mannucci
Cancer Cell|May 10, 2022
Boosting anticancer immunotherapy through androgen receptor blockadeLaura Pala, Tommaso De Pas, Fabio Conforti
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2019
Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative TumorsFabio Conforti, Laura Pala
Expert Opinion on Drug Safety|September 1, 2021
The effect of patient sex on the efficacy and safety of anticancer immunotherapyLaura Pala, Fabio Conforti
Acta Diabetologica|April 15, 2008
Time to insulin in type-2 diabetes: high hurdles or Santiago way?Carlo Maria Rotella, Laura Pala
Oncotarget|August 23, 2018
Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune systemFabio Conforti, Laura Pala, Aron Goldhirsch
Molecules (Basel, Switzerland)|August 23, 2020
Modified Enzyme Substrates for the Detection of Bacteria: A ReviewLaura Pala, Teja Sirec, Urs Spitz
The Lancet. Oncology|March 6, 2020
Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapyLaura Pala, Fabio Conforti, Aron Goldhirsch
Acta Diabetologica|April 5, 2019
Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trialsLaura Pala, Ilaria Dicembrini, Edoardo Mannucci
The New England Journal of Medicine|February 19, 2025
Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast CancerFabio Conforti, Chiara Oriecuia, Laura Pala
International Journal of Endocrinology and Metabolism|December 19, 2013
Role of insulin in the type 2 diabetes therapy: past, present and futureCarlo Maria Rotella, Laura Pala, Edoardo Mannucci
Cancer Cell|May 10, 2022
Boosting anticancer immunotherapy through androgen receptor blockadeLaura Pala, Tommaso De Pas, Fabio Conforti
Pageof 13